J. Hackman

T-SPOT.TB responses during treatment of pulmonary tuberculosis

S. Ribeiro, K. Dooley, J. Hackman, 2009, BMC infectious diseases.

Three months of rifapentine and isoniazid for latent tuberculosis infection.

J. Hackman, R. Chaisson, M. Conde, 2011, The New England journal of medicine.

Human immunodeficiency virus-seronegative adults with extrapulmonary tuberculosis have abnormal innate immune responses.

J. Hackman, R. Chaisson, S. Dorman, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Repeated Administration of High-Dose Intermittent Rifapentine Reduces Rifapentine and Moxifloxacin Plasma Concentrations

K. Dooley, J. Hackman, R. Chaisson, 2008, Antimicrobial Agents and Chemotherapy.

Decreased CD4+ lymphocytes and innate immune responses in adults with previous extrapulmonary tuberculosis.

J. Hackman, J. Schiffer, S. Holland, 2006, The Journal of allergy and clinical immunology.

A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users.

J. Hackman, R. Chaisson, R. Moore, 2001, The American journal of medicine.

Three months of rifapentine and isoniazid for latent tuberculosis infection.

J. Hackman, R. Chaisson, M. Conde, 2011, The New England journal of medicine.